)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Dancann Pharma
Dancann Pharma (DANCAN) investor relations material
Dancann Pharma has been delisted
Dancann Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary27 Oct, 2025
Executive summary
Q3 2025 marked by organizational changes, including the CEO stepping down and a new interim CEO appointed, with a permanent successor planned.
The company is focused on profitability, operational efficiency, and capital discipline amid ongoing market stabilization.
Active divestment process for the Biotech Pharm 1 (BP1) facility continues, with interest from several parties.
Financial highlights
Net sales for Q3 2025 were DKK 1,618 thousand, down from DKK 1,855 thousand in Q3 2024.
EBITDA for Q3 2025 was DKK -1,038 thousand, compared to DKK -901 thousand in Q3 2024.
Operating profit (EBIT) for Q3 2025 was DKK -1,535 thousand, versus DKK -1,420 thousand in Q3 2024.
Cash flow for Q3 2025 was DKK -1,110 thousand, compared to DKK 5,748 thousand in Q3 2024.
Equity at period end was DKK 7,064 thousand, down from DKK 13,310 thousand a year earlier.
Outlook and guidance
The company remains committed to improving operational performance and achieving sustainable earnings over time.
Focus areas include executing the Maturity 2028 strategy and managing the voluntary delisting process.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Dancann Pharma
- Q2 2025 saw declining sales and earnings, but new products and regulatory wins support future growth.DANCAN
Q2 2025 - Revenue up 43.6% YoY, but regulatory delays push new launches to 2025.DANCANQ3 2024
- Record revenue, positive EBITDA, and a clean balance sheet signal strong momentum.DANCANQ2 2024
- Product approvals and pipeline expansion position DanCann Pharma for future growth.DANCANQ1 2025
- Revenue up 27.8% YoY, but margin pressure and regulatory delays persist.DANCANQ4 2024
Dancann Pharma
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Dancann Pharma is a pharmaceutical company focused on the development and distribution of medical cannabis and cannabinoid-based therapies. It serves healthcare providers and patients in regulated markets. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Spotlight Stock Market.